These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28128990)

  • 1. Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
    Xu L; Bian W; Gu XH; Shen C
    COPD; 2017 Apr; 14(2):245-250. PubMed ID: 28128990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema.
    Kokuho N; Ishii T; Kamio K; Hayashi H; Kurahara M; Hattori K; Motegi T; Azuma A; Gemma A; Kida K
    COPD; 2015 Aug; 12(4):347-54. PubMed ID: 25244495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism in matrix metalloproteinase-9 and transforming growth factor-β1 and susceptibility to combined pulmonary fibrosis and emphysema in a Chinese population.
    Xu L; Bian W; Gu XH; Shen C
    Kaohsiung J Med Sci; 2017 Mar; 33(3):124-129. PubMed ID: 28254114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
    Papaioannou AI; Kostikas K; Manali ED; Papadaki G; Roussou A; Spathis A; Mazioti A; Tomos I; Papanikolaou I; Loukides S; Chainis K; Karakitsos P; Griese M; Papiris S
    PLoS One; 2016; 11(6):e0157789. PubMed ID: 27337142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
    Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
    Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
    Sato S; Koike T; Hashimoto T; Ishikawa H; Okada A; Watanabe T; Tsuchida M
    Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):216-23. PubMed ID: 27052999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
    Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
    Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
    Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
    Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study.
    Ikuyama Y; Ushiki A; Kosaka M; Akahane J; Mukai Y; Araki T; Kitaguchi Y; Tateishi K; Urushihata K; Yasuo M; Yamamoto H; Hanaoka M
    BMC Pulm Med; 2020 May; 20(1):144. PubMed ID: 32434532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of lymphocytes and PIIINP with the combined pulmonary fibrosis and emphysema].
    Wei XH; Wu XY; Wang JH; Thakur A; Ma AQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):675-8. PubMed ID: 20619092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema.
    Rogliani P; Mura M; Mattia P; Ferlosio A; Farinelli G; Mariotta S; Graziano P; Pezzuto G; Ricci A; Saltini C; Orlandi A
    Respir Med; 2008 Dec; 102(12):1753-61. PubMed ID: 18723334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF.
    Demirdöğen E; Görek Dilektaşlı A; Acet Öztürk NA; Yeşilbursa D; Budak F; Coşkun F; Öztürk A; Ursavaş A; Özkaya G; Karadağ M; Uzaslan E
    Sarcoidosis Vasc Diffuse Lung Dis; 2022 Dec; 39(4):e2022035. PubMed ID: 36533605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone.
    Awano N; Inomata M; Ikushima S; Yamada D; Hotta M; Tsukuda S; Kumasaka T; Takemura T; Eishi Y
    Histopathology; 2017 May; 70(6):896-905. PubMed ID: 27992963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.
    Ryerson CJ; Hartman T; Elicker BM; Ley B; Lee JS; Abbritti M; Jones KD; King TE; Ryu J; Collard HR
    Chest; 2013 Jul; 144(1):234-240. PubMed ID: 23370641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the bronchoalveolar lavage fluid and the serum of patients with idiopathic pulmonary fibrosis].
    Wei LQ; Li ZH; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):399-402. PubMed ID: 17045024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema.
    Zhao Y; Cui A; Wang F; Wang XJ; Chen X; Jin ML; Huang KW
    Chin Med J (Engl); 2012 Sep; 125(17):3015-21. PubMed ID: 22932172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Krebs von den Lungen-6 as a potential biomarker for distinguishing combined pulmonary fibrosis and emphysema from chronic obstructive pulmonary disease: A retrospective study.
    Zhou A; Zhang X; Lu R; Peng W; Wang Y; Tang H; Pan P
    Heliyon; 2024 Aug; 10(15):e35099. PubMed ID: 39165953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
    Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
    BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema].
    Ma JW; Li ZH; Xu H; Wang HJ; Kang J; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):173-6. PubMed ID: 23856138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema.
    Cornwell WD; Kim C; Lastra AC; Dass C; Bolla S; Wang H; Zhao H; Ramsey FV; Marchetti N; Rogers TJ; Criner GJ
    Biomarkers; 2019 May; 24(3):232-239. PubMed ID: 30411980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.